Le Lézard
Classified in: Health
Subject: PDT

InventHelp Inventors Develop New Kind of Adhesive Bandage to Apply Pressure (CHK-1029)


PITTSBURGH, May 27, 2024 /PRNewswire/ -- "My husband needed a better way to apply pressure to the venipuncture site after 3-4 hours of dialysis treatment. Many times, he is too weak to apply pressure on the site for an extended time. We thought there should be a bandage to apply the same pressure as the forefinger and middle finger to stop the bleeding," said an inventor, from Joliet, Ill., "so we invented the PRESSURE AID. Our design offers an alternative to traditional adhesive bandages that don't hold gauze effectively and tend to fall off easily."

The invention provides an improved padded bandage for applying pressure to a wound or venipuncture site. In doing so, it helps stop bleeding and encourages clotting. It also would keep the wound clean and protected. The invention features a simple and effective design that is easy to apply so it is ideal for hospitals, nursing homes, testing/lab facilities, households, etc. Additionally, a prototype model is available upon request.

The original design was submitted to the Chicago sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 22-CHK-1029, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.

SOURCE InventHelp


These press releases may also interest you

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

3 jui 2024
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: